SCHEMBL21995806

SCHEMBL21995806

NNC(=O)c1ccc(SC(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.56
EPHX2 P34913 1/20 0.56
NR1H4 Q96RI1 1/20 0.56
KCNK2 O95069 9/20 0.55
KCNK10 P57789 7/20 0.55
MPO P05164 1/20 0.52
CYP3A4 P08684 1/20 0.52
KDM5A P29375 1/20 0.52
BLM P54132 1/20 0.52
GFER P55789 1/20 0.52
PMP22 Q01453 1/20 0.52
HIF1A Q16665 1/20 0.52
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
OGG1 O15527 1/20 0.50
LMNA P02545 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KIF11 P52732 1/20 0.50
PTPRZ1 P23471 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13485813 0.83 TRPV1 (0.58) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL6497472 0.81 TRPV1 (0.56) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL6497474 0.81 PLK1 (0.61) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL16610094 0.80 EPHX2 (0.58) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL2541283 0.79 KIF11 (0.54) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL2107844 0.79 OGG1 (0.61) MPOCYP3A4KDM5ABLMGFER
SCHEMBL10919991 0.78 LMNA (0.53) TRPV1EPHX2NR1H4KCNK2KCNK10
SCHEMBL17124383 0.78 MPO (0.61) MPOCYP3A4KDM5ABLMGFER
Trifluoroacetic Acid SCHEMBL2107013 0.77 OGG1 (0.50) KCNK2KCNK10MPOCYP3A4KDM5A
SCHEMBL16599531 0.77 EPHX2 (0.59) TRPV1EPHX2NR1H4KCNK2KCNK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281108-B2 Pyrrolidinone derivatives as formyl peptide 2 receptor agonists BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-22 US disclosed
CN-113166134-B Pyrrolidone derivatives as formyl peptide 2 receptor agonists 百时美施贵宝公司 2024-06-14 CN disclosed
EP-3887366-B1 PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS BRISTOL MYERS SQUIBB CO (US) 2023-09-27 EP disclosed
US-20220002281-A1 PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS BRISTOL MYERS SQUIBB CO (US) 2022-01-06 US disclosed
EP-3887366-A1 PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS Bristol-Myers Squibb Company (US) 2021-10-06 EP disclosed
CN-113166134-A Pyrrolidone derivatives as formyl peptide 2 receptor agonists 百时美施贵宝公司 2021-07-23 CN disclosed
WO-2020112583-A1 PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2020-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281108-B2 Pyrrolidinone derivatives as formyl peptide 2 receptor agonists FPR1, FPR2, FPR3 TRPV1 367/4885EPHX2 1881/4885NR1H4 175/4885
US-20220002281-A1 PYRROLIDINONE DERIVATIVES AS FORMYL PEPTIDE 2 RECEPTOR AGONISTS FPR1, FPR2, FPR3 TRPV1 367/4885EPHX2 1881/4885NR1H4 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.